Delivery Order SPE2DB24D1021-SPE2DB25FEZKA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.88 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a federal medical supply provider,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the company's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,083.70 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price, non-competitive delivery order is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used in diabetes management. This competitively awarded, non-set-aside contract has a ceiling value of $2,165.52 and firm fixed pricing, with an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and is scheduled for completion by August 8, 2025. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZKADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order issued under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The order represents a child contract utilizing the broader SPE2DX vehicle, valued at approximately $1 billion and running through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This contract award carries no set-aside designation and was competitively awarded through DLA's Medical Supply Chain, reflecting AmerisourceBergen's established capability to fulfill federal medical procurement requirements. The Dexcom G7 sensors being procured are continuous glucose monitoring devices used in military healthcare systems to support diabetes management for service members and military beneficiaries. AmerisourceBergen's role as a prime pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for the federal government's medical supply chain, delivering a comprehensive portfolio of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/7/25 |